Search clinical trials for: PegIntron Pen

Total 8299 results

University Health Network, Toronto
Schering-Plough

Terminated

EXtended Therapy in Hepatitis C Genotype 3 Infected Patients (EXACT-R(3))

Chronic Hepatitis C

Canada
Becton, Dickinson and Company

Completed

Comparative User Experiences With BD Nano™ PRO 32G Extra Thin Wall Pen Needle vs the Terumo Nanopass® 34G Pen Needle

Diabetes

United States
Semmelweis University
Hungarian Scientific Research Fund

Completed

Post-operative Blood Flow Measurements of the Oral Mucosa (LASCAM)

Gingival Recession

Hungary
Filip Krag Knop
Zealand Pharma

Active, not recruiting

Treatment of Post-bariatric Hypoglycaemia (SHERRY)

Hyperinsulinemic Hypoglycemia | Postprandial Hypoglycemia

Denmark
Hoffmann-La Roche

Completed

PROPHESYS 2: An Observational Study on Predictors of Response in Treatment-naïve Patients With Chronic Hepatitis C Treated With Pegasys (Peginterferon Alfa-2a) or Peginterferon-alfa-2b

Hepatitis C, Chronic

Belgium, Ireland, Italy, United Kingdom
PATH
World Health Organization; University of Cape Town

Completed

Comparative Study of Bacille Calmette Guerin (BCG) Delivery Via Disposable Syringe Jet Injector and Needle & Syringe

Tuberculosis

South Africa
UPECLIN HC FM Botucatu Unesp

Completed

Factors Associated to Success of Hepatitis C Therapy

Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted

Brazil
Hoffmann-La Roche

Completed

PROPHESYS 3: Observational Study on Predictors of Response in Patients With Treatment-naïve Chronic Hepatitis C Initiated on Treatment With Pegasys (Peginterferon Alfa-2a) or Peginterferon-alfa-2b

Hepatitis C, Chronic

United States, Puerto Rico
Luis Montaner
National Institute of Allergy and Infectious Diseases (NIAID); University of... and other collaborators

Unknown

Peg-Interferon Alpha 2b Combined With Two Intravenous Broadly HIV-1 Neutralizing Antibodies 3BNC117 and 10-1074 (BEAT-2) (BEAT-2)

HIV/AIDS | HIV | HIV-1 Infection

United States
Becton, Dickinson and Company

Terminated

Evaluation of a 4mmx32G Pen Needle for Injection of Basal Insulin Doses Above 40 Units

Diabetes Mellitus, Type 2

United States, Canada
Tarveda Therapeutics

Completed

PEN-221 in Somatostatin Receptor 2 Expressing Advanced Cancers Including Neuroendocrine and Small Cell Lung Cancers

Neuroendocrine Tumors | Neuroendocrine Carcinoma | Carcinoma, Small Cell Lung

United States, United Kingdom
All India Institute of Medical Sciences, New Delhi

Not yet recruiting

Efficacy of Smartphone Based Digital Application in Improving Headache Related Parameters in Patients With Migraine

Migraine

India
Institut Rafael

Active, not recruiting

Patient Preference Between a Prefilled Syringe or a Prefilled Pen Device for Administration of Pegfilgrastim (PELGRAZ)

Patient Satisfaction | Patient Preference | Febrile Neutropenia, Drug-Induced

France
ImPACT Applications, Inc.

Terminated

Development of a Neurocognitive Screening Test

Brain Concussion | Mild Cognitive Impairment

United States
DEKK-TEC, Inc.

No longer available

A Phase I Trial of DM-CHOC-PEN in Adolescent and Young Adult (AYA) Subjects With Advanced Cancers

Advanced Cancer

United States
Bristol-Myers Squibb

Completed

Safety and Efficacy of Daclatasvir (BMS-790052) Plus Standard of Care (Pegylated-interferon Alpha-2b and Ribavirin) in Japanese Patients

Hepatitis C Infection

Japan
Merck Sharp & Dohme LLC

Completed

Post Marketing Observational Study of Retreatment of Chronic Hepatitis C With Peginterferon Alpha and Ribavirin (Study P06011) (POMOSCH)

Hepatitis C, Chronic
Merck Sharp & Dohme LLC

Withdrawn

Evaluation of Hepatic Pharmacokinetics for Grazoprevir (MK-5172) in Participants With Chronic Hepatitis C (MK-5172-022)

Chronic Hepatitis C
DEKK-TEC, Inc.
National Cancer Institute (NCI)

Completed

DM-CHOC-PEN Plus Radiation for Brain Tumors

Advanced Cancer

United States
University of Cincinnati

Completed

Positron Emission Mammography (PEM) Biopsy Accessory for the Diagnosis of Breast Cancer

Breast Cancer

United States
Merck Sharp & Dohme LLC

Completed

Effect of Insulin Resistance on the Safety and Efficacy of Pegylated Interferon and Ribavirin Treatment in HCV (Study P05562)

Hepatitis C, Chronic | Hepatitis C Virus
Merck Sharp & Dohme LLC

Completed

Safety and Efficacy of PegIntron and Rebetol Combination Therapy in Patients With Chronic Hepatitis C in Japan (Study P04505)

Hepatitis C | Hepatitis C, Chronic
University Hospital Schleswig-Holstein
Dermatologic Cooperative Oncology Group

Completed

Combined Treatment of Sorafenib and Pegylated Interferon α2b in Stage IV Metastatic Melanoma (SoraPeg)

Melanoma

Germany
amfAR, The Foundation for AIDS Research
Kirby Institute

Completed

HCV Treatment in HIV Co-Infected Patients in Asia

Hepatitis C | HIV

Vietnam, Malaysia, Indonesia, Thailand
Vertex Pharmaceuticals Incorporated
Janssen Pharmaceuticals

Terminated

An Open-Label Study of the Effect of Telaprevir in Combination With Peginterferon Alfa-2b and Ribavirin in Pediatric Subjects Infected With Hepatitis C Virus

Hepatitis C

United States, United Kingdom, Spain, Belgium, Italy, Germany
Merck Sharp & Dohme LLC

Completed

Evaluating Fine Needle Aspiration to Measure Hepatic Vaniprevir (MK-7009) Concentrations in Participants With Chronic Hepatitis C (MK-7009-048)

Chronic Hepatitis C
Alexandria University

Recruiting

Efficacy of Low-level Laser Acupuncture and Microcurrent Electrical Stimulation on Gag Reflex on Children

Gagging

Egypt
University of Pittsburgh
American Academy of Child Adolescent Psychiatry.

Completed

Using a Text-message System to Engage Depressed Adolescents in Cognitive-behavioral Therapy Homework

Major Depressive Disorder | Cognitive Behavior Therapy | Text Messaging
Uppsala University
Karolinska University Hospital; Uppsala University Hospital

Completed

A Study Comparing Imatinib and Imatinib/Pegylated Interferon in Chronic Myeloid Leukemia

Health Care Quality | Health Care Evaluation

Sweden
Merck Sharp & Dohme LLC

Completed

Extended Treatment With PEG-Intron® and Rebetol® in Patients With Genotype 1 Chronic Hepatitis C and Slow Virologic Response (Study P03685)

Hepatitis C, Chronic
Weill Medical College of Cornell University
Merck Sharp & Dohme LLC

Terminated

Pegylated Interferon Alpha-2b in Early Primary Myelofibrosis

Myelofibrosis

United States
University of Erlangen-Nürnberg Medical School

Recruiting

Analyse the Effect of Semaglutide on Vascular Structure and Function in Patients With Early Type 2 Diabetes (SEMA)

Diabetes Mellitus, Type 2

Germany
Children's Hospital of Philadelphia

Completed

Trial Regarding the Acceptability of Audiotape Intimate Partner Violence (IPV) Screening

Domestic Violence

United States
Azienda USL Modena

Completed

1L-PEG-Asc Solution for Bowel Preparation in an "Open Access" Colonoscopy Booking System: Evaluation of Adverse Events

Bowel Preparation

Italy
University of Arizona
Emory University; National Center for Complementary and Integrative Health...

Withdrawn

Inflammation, Stress & Social Behavior: Using Ecological Assessments & Model Systems to Enhance Relevance to Health Outcomes

Hepatitis C

United States
Merck Sharp & Dohme LLC

Completed

Peginterferon Dose Evaluations for Previously Untreated Subjects With Chronic Hepatitis C Infected With Genotype 1 (Study P03471)

Hepatitis C, Chronic
University of Manitoba
Saskatchewan Pulse Growers; Alberta Pulse Growers

Completed

PERFECT Project - Part 1 - Study 2

Diabetes Prevention | Obesity Prevention
Merck Sharp & Dohme LLC

Completed

Evaluation of Satisfaction in Patients Receiving PegIntron Pen/Rebetol for Hepatitis C (Study P04067) (SATISFACTION)

Hepatitis C, Chronic
Levenson, David I., M.D.

Terminated

Adaptive Device for Insulin Pens for Arthritic Patients

Diabetes Mellitus | Arthritis

United States
LG Chem

Unknown

Relative Bioavailability Among Different Eutropin Formulations

Relative Bioavailability

Korea, Republic of
Liver Institute of Virginia
Merck Sharp & Dohme LLC; Chronic Liver Disease Foundation

Unknown

A Pilot Study to Treat Patients With Chronic Hepatitis C Virus (HCV) Genotype 1 and End-Stage Renal Disease (ESRD)

End Stage Renal Disease | Chronic Hepatitis C

United States
Hui-Yu Lin

Recruiting

Laser Acupuncture Improves Constipation for Critical Care Nurses During the COVlD-19 Pandemic

Nurse

Taiwan
Peking Union Medical College Hospital
Zhejiang Cancer Hospital; Xiangya Hospital of Central South University; Sun Yat-sen... and other collaborators

Recruiting

Application of KANG FU PEN in Radical Concurrent Radiotherapy and Chemotherapy for Cervical Cancer to Prevent and Treat Radiation-induced Rectal Injury

Cervical Cancer | Radiotherapy Side Effect | Radiotherapy; Complications

China
Lund University
Swedish Cancer Foundation; ALF Swedish Government Grant

Completed

The Role of Follicle Stimulating Hormone in Advanced Prostate Cancer

Prostate Cancer Recurrent

Sweden
Merck Sharp & Dohme LLC

Completed

The Effect of Boceprevir in Russian Participants Diagnosed With Chronic Hepatitis C Genotype 1 (P08160)

Chronic Hepatitis C Genotype 1
Merck Sharp & Dohme LLC

Completed

A Study to Evaluate the Efficacy and Safety of Boceprevir Added to Standard of Care Therapy in Previously Treated Participants With Chronic Hepatitis C Genotype 1 and Cirrhosis (MK-3034-105)

Hepatitis C
Merck Sharp & Dohme LLC

Completed

Treatment of Patients With Chronic Hepatitis C With PegIntron as Monotherapy or in Combination With Ribavirin (Study P04437)(COMPLETED) (ADEQUATION)

Hepatitis C, Chronic | Hepacivirus
Merck Sharp & Dohme LLC

Completed

Pharmacoeconomic Study Assessing the Cost of Chronic Hepatitis C Treatment With Peginterferon Alfa-2b (PegIntron) and Ribavirin (Rebetol) in the Czech Republic (Study P04588)(COMPLETED)

Hepatitis C | Hepatitis C, Chronic
Schering-Plough

Completed

Satisfaction in Patients Receiving the PegIntron Pen Plus Rebetol for Hepatitis C (Study P04244)(COMPLETED)

Hepatitis C, Chronic | Hepacivirus
University of Maryland, Baltimore

Active, not recruiting

Improving Glycemic Control in DM2 Patients in the Ambulatory Setting

Diabetes Mellitus

United States

3

Subscribe